Trastuzumab (T) and pertuzumab (P)-mediated antibody-dependent cell-mediated cytotoxicity (ADCC) in tyrosine kinase inhibitor (TKI)-treated breast cancer (BC) cell lines.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.643 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 643-643 ◽

Author(s):

Denis Collins ◽

Norma O'Donovan ◽

Thamir Mahgoub ◽

Kathy Gately ◽

Clare Hughes ◽

...

Keyword(s):

Breast Cancer ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Kinase Inhibitor ◽

Dependent Cell ◽

Treated Breast ◽

Treated Breast Cancer

Download Full-text

HER2-targeted antibody dependent cell-mediated cytotoxicity (ADCC) mediated by NK cells against tyrosine kinase inhibitor (TKI)-treated breast cancer (BC) cell lines

Annals of Oncology ◽

10.1093/annonc/mdz095.055 ◽

2019 ◽

Vol 30 ◽

pp. iii18

Author(s):

D.M. Collins ◽

N. Gaynor ◽

N.T. Conlon ◽

N. O’Donovan ◽

J.P. Crown

Keyword(s):

Breast Cancer ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Nk Cells ◽

Kinase Inhibitor ◽

Dependent Cell ◽

Treated Breast ◽

Treated Breast Cancer

Download Full-text

Effect of a combination of tyrosine kinase inhibitor imatinib with doxorubicin shows in breast cancer cell lines.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.e13657 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. e13657-e13657

Author(s):

L. Dahmke ◽

M. T. Weigel ◽

M. Bauer ◽

C. Schem ◽

I. Alkatout ◽

...

Keyword(s):

Breast Cancer ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cancer Cell ◽

Breast Cancer Cell ◽

Kinase Inhibitor ◽

Cancer Cell Lines ◽

Breast Cancer Cell Lines

Download Full-text

P192 CUB-domain containing protein (CDCP1)-mediated anchorage free survival and migratory properties in breast cancer cell lines are not affected by tyrosine kinase inhibitor lapatinib

10.1016/s0960-9776(11)70134-5 ◽

2011 ◽

Vol 20 ◽

pp. S42

Author(s):

J. Seidel ◽

K. Kunc ◽

K. Possinger ◽

D.I. Lüftner

Keyword(s):

Breast Cancer ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cancer Cell ◽

Breast Cancer Cell ◽

Kinase Inhibitor ◽

Breast Cancer Cell Lines ◽

Free Survival ◽

Download Full-text

194. Combining the Dual Tyrosine Kinase Inhibitor, Lapatinib, with HER2 Specific Cytotoxic T-Lymphocytes in the Treatment of HER2 Overexpressing Breast Cancer

Molecular Therapy ◽

10.1016/s1525-0016(16)35998-6 ◽

2012 ◽

Vol 20 ◽

pp. S77

Keyword(s):

Breast Cancer ◽

T Lymphocytes ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cytotoxic T Lymphocytes ◽

Kinase Inhibitor

Download Full-text

Radiosensitization of human breast cancer cells by a novel ErbB family receptor tyrosine kinase inhibitor

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/s0360-3016(00)01358-4 ◽

2000 ◽

Vol 48 (5) ◽

pp. 1519-1528 ◽

Author(s):

Geetha S Rao ◽

Susan Murray ◽

Stephen P Ethier

Keyword(s):

Breast Cancer ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cancer Cells ◽

Receptor Tyrosine Kinase ◽

Human Breast Cancer ◽

Breast Cancer Cells ◽

Kinase Inhibitor ◽

Human Breast Cancer Cells ◽

Download Full-text

Therapeutic activity of DCC‐2036, a novel tyrosine kinase inhibitor, against triple‐negative breast cancer patient‐derived xenografts by targeting AXL/MET

International Journal of Cancer ◽

10.1002/ijc.31915 ◽

2018 ◽

Vol 144 (3) ◽

pp. 651-664 ◽

Author(s):

Yingying Shen ◽

Wei Zhang ◽

Jianghua Liu ◽

Jun He ◽

Renxian Cao ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patient ◽

Tyrosine Kinase ◽

Breast Cancer Patient ◽

Tyrosine Kinase Inhibitor ◽

Triple Negative Breast Cancer ◽

Triple Negative ◽

Kinase Inhibitor ◽

Therapeutic Activity

Download Full-text

Glucose-6-phosphate dehydrogenase blockade potentiates tyrosine kinase inhibitor effect on breast cancer cells through autophagy perturbation

Journal of Experimental & Clinical Cancer Research ◽

10.1186/s13046-019-1164-5 ◽

2019 ◽

Vol 38 (1) ◽

Author(s):

Luigi Mele ◽

Marcella la Noce ◽

Francesca Paino ◽

Tarik Regad ◽

Sarah Wagner ◽

...

Keyword(s):

Breast Cancer ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cancer Cells ◽

Breast Cancer Cells ◽

Kinase Inhibitor ◽

Glucose 6 Phosphate Dehydrogenase

Download Full-text

Calpain4 Regulates The Response Of Non-Small Cell Lung Cancer Cell Lines To EGFR Tyrosine Kinase Inhibitor Erlotinib

10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a6288 ◽

2012 ◽

Author(s):

Sucheta Kulkarni ◽

Leya Saju ◽

Carol F. Farver

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitor ◽

Kinase Inhibitor ◽

Lung Cancer Cell ◽

Small Cell Lung ◽

Egfr Tyrosine Kinase Inhibitor

Download Full-text

Tyrosine kinase inhibitor resistance in chronic myeloid leukemia cell lines: investigating resistance pathways

Leukemia & Lymphoma ◽

10.3109/10428194.2011.591013 ◽

2011 ◽

Vol 52 (11) ◽

pp. 2139-2147 ◽

Author(s):

Carine Tang ◽

Lisa Schafranek ◽

Dale B. Watkins ◽

Wendy T. Parker ◽

Sarah Moore ◽

...

Keyword(s):

Chronic Myeloid Leukemia ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Myeloid Leukemia ◽

Kinase Inhibitor ◽

Leukemia Cell ◽

Leukemia Cell Lines ◽

Inhibitor Resistance ◽

Myeloid Leukemia Cell

Download Full-text

P4-01-21: An Estrogen-Inducible Transcription Factor FOXP1 Promotes Estrogen-Dependent Cell Proliferation of Breast Cancer Cells and Is Associated with 5-Year Disease-Free Survival in Patients with Tamoxifen-Treated Breast Cancer.

10.1158/0008-5472.sabcs11-p4-01-21 ◽

2011 ◽

Author(s):

T Shigekawa ◽

N Ijichi ◽

K Ikeda ◽

K Horie-Inoue ◽

C Shimizu ◽

...

Keyword(s):

Breast Cancer ◽

Cell Proliferation ◽

Transcription Factor ◽

Breast Cancer Cells ◽

Disease Free Survival ◽

Free Survival ◽

Dependent Cell ◽

Treated Breast ◽

Disease Free ◽

Treated Breast Cancer

Download Full-text